Covered recipient · General Payments record
RAJ A NARAYAN
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2018–2024
$1,808.03
- Reported across 124 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $656.67 | 55 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $504.56 | 46 |
| Alkermes, Inc. | $55.30 | 3 |
| Teva Pharmaceuticals USA, Inc. | $33.15 | 2 |
| Axsome Therapeutics, Inc. | $21.66 | 1 |
| Noven Therapeutics, LLC | $14.99 | 1 |
| Supernus Pharmaceuticals, Inc. | $13.86 | 1 |
| IRONSHORE PHARMACEUTICALS INC. | $13.15 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (55)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2018201920222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $7.14 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105099765 | CMS |
| ABBVIE INC. | $6.25 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105099767 | CMS |
| ABBVIE INC. | $22.42 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105099769 | CMS |
| ABBVIE INC. | $6.17 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105099771 | CMS |
| ABBVIE INC. | $7.39 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105099773 | CMS |
| ABBVIE INC. | $8.56 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105099775 | CMS |
| ABBVIE INC. | $9.81 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105099777 | CMS |
| ABBVIE INC. | $7.05 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105099779 | CMS |
| ABBVIE INC. | $14.66 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105099781 | CMS |
| ABBVIE INC. | $21.88 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105099783 | CMS |
| ABBVIE INC. | $6.83 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105099785 | CMS |
| ABBVIE INC. | $14.64 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105099787 | CMS |
| ABBVIE INC. | $5.25 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105099789 | CMS |
| ABBVIE INC. | $7.15 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105099791 | CMS |
| ABBVIE INC. | $6.84 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105099793 | CMS |
| ABBVIE INC. | $5.75 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105099795 | CMS |
| ABBVIE INC. | $8.21 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105099797 | CMS |
| ABBVIE INC. | $23.22 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105099799 | CMS |
| ABBVIE INC. | $8.65 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105099801 | CMS |
| ABBVIE INC. | $21.31 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105099803 | CMS |
| ABBVIE INC. | $7.11 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105099805 | CMS |
| ABBVIE INC. | $7.93 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105099807 | CMS |
| ABBVIE INC. | $10.69 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105099809 | CMS |
| ABBVIE INC. | $9.04 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105099811 | CMS |
| ABBVIE INC. | $9.47 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105099813 | CMS |
| ABBVIE INC. | $13.70 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105099815 | CMS |
| ABBVIE INC. | $8.47 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105099817 | CMS |
| ABBVIE INC. | $20.29 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105099819 | CMS |
| ABBVIE INC. | $10.67 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105099821 | CMS |
| ABBVIE INC. | $9.25 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105099823 | CMS |
| ABBVIE INC. | $7.74 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105099825 | CMS |
| ABBVIE INC. | $22.42 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105099827 | CMS |
| ABBVIE INC. | $6.43 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105099829 | CMS |
| ABBVIE INC. | $5.51 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105099831 | CMS |
| ABBVIE INC. | $22.74 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105099833 | CMS |
| ABBVIE INC. | $6.12 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105099835 | CMS |
| ABBVIE INC. | $6.37 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105099837 | CMS |
| ABBVIE INC. | $7.62 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105099839 | CMS |
| ABBVIE INC. | $8.02 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105099841 | CMS |
| ABBVIE INC. | $13.91 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105099843 | CMS |
| ABBVIE INC. | $9.75 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105099845 | CMS |
| ABBVIE INC. | $13.63 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105099847 | CMS |
| ABBVIE INC. | $8.62 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105099849 | CMS |
| ABBVIE INC. | $7.58 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105099851 | CMS |
| ABBVIE INC. | $23.94 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105099853 | CMS |
| ABBVIE INC. | $8.36 | 12/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105099855 | CMS |
| Alkermes, Inc. | $23.37 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120561230 | CMS |
| Alkermes, Inc. | $15.67 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120561232 | CMS |
| Alkermes, Inc. | $16.26 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120561234 | CMS |
| Axsome Therapeutics, Inc. | $21.66 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148312472 | CMS |
| IRONSHORE PHARMACEUTICALS INC. | $13.15 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146312659 | CMS |
| Noven Therapeutics, LLC | $14.99 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084824463 | CMS |
| Supernus Pharmaceuticals, Inc. | $13.86 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147820583 | CMS |
| Teva Pharmaceuticals USA, Inc. | $17.25 | 03/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151689360 | CMS |
| Teva Pharmaceuticals USA, Inc. | $15.90 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151689447 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.